{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:18:37Z","timestamp":1793837917036,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"crossref","award":["ORF-2026-657"],"award-info":[{"award-number":["ORF-2026-657"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46514-w","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:45:48Z","timestamp":1775544348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Montelukast attenuates diclofenac sodium-induced cardiotoxicity in male rats via targeting Wnt\/\u03b2-catenin pathway"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5323-5781","authenticated-orcid":false,"given":"Sary","family":"Alsanea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6530-0139","authenticated-orcid":false,"given":"Shaykhah","family":"Albuhayri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3171-771X","authenticated-orcid":false,"given":"Layla","family":"Alkharashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-4202","authenticated-orcid":false,"given":"Nemat","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7569-4287","authenticated-orcid":false,"given":"Abdullah F.","family":"AlAsmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4966-2358","authenticated-orcid":false,"given":"Maha","family":"Arafah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7311-1412","authenticated-orcid":false,"given":"Iman","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9434-1281","authenticated-orcid":false,"given":"Rehab","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0482-5363","authenticated-orcid":false,"given":"Hala","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"46514_CR1","first-page":"671","volume":"19","author":"NA Abdulmajeed","year":"2015","unstructured":"Abdulmajeed, N. A., Alnahdi, H. S., Ayas, N. O. & Mohamed, A. M. Amelioration of cardiotoxic impacts of diclofenac sodium by vitamin B complex. Eur. Rev. Med. Pharmacol. Sci. 19, 671\u2013681 (2015).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"46514_CR2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.lfs.2017.05.018","volume":"180","author":"SK Goswami","year":"2017","unstructured":"Goswami, S. K. et al. Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers. Life Sci. 180, 114\u2013122. https:\/\/doi.org\/10.1016\/j.lfs.2017.05.018 (2017).","journal-title":"Life Sci."},{"key":"46514_CR3","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ijcard.2016.08.233","volume":"223","author":"R Ghosh","year":"2016","unstructured":"Ghosh, R., Goswami, S. K., Feitoza, L. F. B. B., Hammock, B. & Gomes, A. V. Diclofenac induces proteasome and mitochondrial dysfunction in murine cardiomyocytes and hearts. Int. J. Cardiol. 223, 923\u2013935. https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.233 (2016).","journal-title":"Int. J. Cardiol."},{"key":"46514_CR4","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1177\/0003134820952834","volume":"87","author":"RW Chang","year":"2021","unstructured":"Chang, R. W., Tompkins, D. M. & Cohn, S. M. Are NSAIDs safe? Assessing the risk-benefit profile of nonsteroidal anti-inflammatory drug use in postoperative pain management. Am. Surg. 87, 872\u2013879. https:\/\/doi.org\/10.1177\/0003134820952834 (2021).","journal-title":"Am. Surg."},{"key":"46514_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/ehjcvp\/pvad018","volume":"9","author":"M Schmidt","year":"2023","unstructured":"Schmidt, M., Arendt-Nielsen, L., Hauge, E. M., S\u00f8rensen, H. T. & Pedersen, L. High- versus low-dose diclofenac and cardiovascular risks: A target trial emulation. Eur. Heart J. Cardiovasc. Pharmacother. 9, 453\u2013461. https:\/\/doi.org\/10.1093\/ehjcvp\/pvad018 (2023).","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"46514_CR6","doi-asserted-by":"publisher","first-page":"117605","DOI":"10.1016\/j.lfs.2020.117605","volume":"254","author":"MH Arafa","year":"2020","unstructured":"Arafa, M. H., Mohammad, N. S. & Atteia, H. H. Rho-kinase inhibitors ameliorate diclofenac-induced cardiotoxicity in chloroquine-treated adjuvant arthritic rats. Life Sci. 254, 117605. https:\/\/doi.org\/10.1016\/j.lfs.2020.117605 (2020).","journal-title":"Life Sci."},{"key":"46514_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/01480545.2022.2069804","volume":"46","author":"A Dogra","year":"2023","unstructured":"Dogra, A. et al. Ameliorating effect of rutin against diclofenac-induced cardiac injury in rats with underlying function of FABP3, MYL3, and ANP. Drug Chem. Toxicol. 46, 597\u2013608. https:\/\/doi.org\/10.1080\/01480545.2022.2069804 (2023).","journal-title":"Drug Chem. Toxicol."},{"key":"46514_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10557-021-07253-4","volume":"37","author":"PN Thai","year":"2023","unstructured":"Thai, P. N. et al. Chronic diclofenac exposure increases mitochondrial oxidative stress, inflammatory mediators, and cardiac dysfunction. Cardiovasc. Drugs Ther. 37, 25\u201337. https:\/\/doi.org\/10.1007\/s10557-021-07253-4 (2023).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"46514_CR9","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse, R. & Clevers, H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell 169, 985\u2013999. https:\/\/doi.org\/10.1016\/j.cell.2017.05.016 (2017).","journal-title":"Cell"},{"key":"46514_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/labinvest.2015.153","volume":"96","author":"D Zhou","year":"2016","unstructured":"Zhou, D., Tan, R. J., Fu, H. & Liu, Y. Wnt\/\u03b2-catenin signaling in kidney injury and repair: A double-edged sword. Lab. Invest. 96, 156\u2013167. https:\/\/doi.org\/10.1038\/labinvest.2015.153 (2016).","journal-title":"Lab. Invest."},{"key":"46514_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Wnt\/\u03b2-catenin signalling: Function, biological mechanisms, and therapeutic opportunities. Signal Transduct. Target. Ther. 7, 3. https:\/\/doi.org\/10.1038\/s41392-021-00762-6 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"46514_CR12","doi-asserted-by":"publisher","first-page":"14886","DOI":"10.1038\/s41598-021-94169-6","volume":"11","author":"T Methatham","year":"2021","unstructured":"Methatham, T., Tomida, S., Kimura, N., Imai, Y. & Aizawa, K. Inhibition of the canonical Wnt signaling pathway by a \u03b2-catenin\/CBP inhibitor prevents heart failure by ameliorating cardiac hypertrophy and fibrosis. Sci. Rep. 11, 14886. https:\/\/doi.org\/10.1038\/s41598-021-94169-6 (2021).","journal-title":"Sci. Rep."},{"key":"46514_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s12012-021-09643-4","volume":"21","author":"P Sen","year":"2021","unstructured":"Sen, P. et al. Wnt\/\u03b2-catenin antagonist pyrvinium exerts cardioprotective effects in polymicrobial sepsis model by attenuating calcium dyshomeostasis and mitochondrial dysfunction. Cardiovasc. Toxicol. 21, 517\u2013532. https:\/\/doi.org\/10.1007\/s12012-021-09643-4 (2021).","journal-title":"Cardiovasc. Toxicol."},{"key":"46514_CR14","doi-asserted-by":"publisher","first-page":"109902","DOI":"10.1016\/j.cbi.2022.109902","volume":"358","author":"S Srivastava","year":"2022","unstructured":"Srivastava, S., Yadav, S., Singh, G. & Bajwa, S. S. Wnt\/\u03b2-catenin antagonist pyrvinium rescues high-dose isoproterenol-induced cardiotoxicity in rats: Biochemical and immunohistological evidences. Chem. Biol. Interact. 358, 109902. https:\/\/doi.org\/10.1016\/j.cbi.2022.109902 (2022).","journal-title":"Chem. Biol. Interact."},{"key":"46514_CR15","doi-asserted-by":"publisher","first-page":"11053","DOI":"10.1111\/jcmm.17028","volume":"25","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. Huoxin pill prevents acute myocardial ischaemia injury via inhibition of Wnt\/\u03b2-catenin signaling. J. Cell. Mol. Med. 25, 11053\u201311062. https:\/\/doi.org\/10.1111\/jcmm.17028 (2021).","journal-title":"J. Cell. Mol. Med."},{"key":"46514_CR16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.kint.2018.11.021","volume":"95","author":"Y Zhao","year":"2019","unstructured":"Zhao, Y. et al. Wnt\/\u03b2-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome. Kidney Int. 95, 815\u2013829. https:\/\/doi.org\/10.1016\/j.kint.2018.11.021 (2019).","journal-title":"Kidney Int."},{"key":"46514_CR17","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/01480545.2020.1730885","volume":"45","author":"HM Hafez","year":"2022","unstructured":"Hafez, H. M. & Hassanein, H. Montelukast ameliorates doxorubicin-induced cardiotoxicity via modulation of p-glycoprotein and inhibition of ROS-mediated TNF-\u03b1\/NF-\u03baB pathways. Drug Chem. Toxicol. 45, 548\u2013559. https:\/\/doi.org\/10.1080\/01480545.2020.1730885 (2022).","journal-title":"Drug Chem. Toxicol."},{"key":"46514_CR18","first-page":"e65046","volume":"12","author":"AA Hemmati","year":"2017","unstructured":"Hemmati, A. A., Olapour, S., Najafzadeh Varzi, H. & Khodayar, M. J. The evaluation of the ameliorative effect of montelukast against arsenic trioxide-induced cardiotoxicity in rats. Jundishapur J. Nat. Pharm. Prod. 12, e65046 (2017).","journal-title":"Jundishapur J. Nat. Pharm. Prod."},{"key":"46514_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/0960327115591372","volume":"35","author":"AE Khodir","year":"2016","unstructured":"Khodir, A. E., Ghoneim, H. A., Rahim, M. A. & Suddek, G. M. Montelukast attenuates lipopolysaccharide-induced cardiac injury in rats. Hum. Exp. Toxicol. 35, 388\u2013397. https:\/\/doi.org\/10.1177\/0960327115591372 (2016).","journal-title":"Hum. Exp. Toxicol."},{"key":"46514_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejphar.2006.07.046","volume":"548","author":"N Shiota","year":"2006","unstructured":"Shiota, N., Shimoura, K. & Okunishi, H. Pathophysiological role of mast cells in collagen-induced arthritis: Study with a cysteinyl leukotriene receptor antagonist, montelukast. Eur. J. Pharmacol. 548, 158\u2013166. https:\/\/doi.org\/10.1016\/j.ejphar.2006.07.046 (2006).","journal-title":"Eur. J. Pharmacol."},{"key":"46514_CR21","first-page":"15","volume":"52","author":"L Ponce","year":"2011","unstructured":"Ponce, L. et al. The effect of montelukast in a model of gouty arthritis induced by sodium monourate crystals. Invest. Clin. 52, 15\u201322 (2011).","journal-title":"Invest. Clin."},{"key":"46514_CR22","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00011-021-01492-9","volume":"70","author":"SA Abdelhady","year":"2021","unstructured":"Abdelhady, S. A. et al. Montelukast potentiates the anti-inflammatory effect of NSAIDs in the rat paw formalin model and simultaneously minimizes the risk of gastric damage. Inflamm. Res. 70, 981\u2013992. https:\/\/doi.org\/10.1007\/s00011-021-01492-9 (2021).","journal-title":"Inflamm. Res."},{"key":"46514_CR23","doi-asserted-by":"publisher","first-page":"e22178","DOI":"10.1002\/ddr.22178","volume":"85","author":"Y Kaya-Yasar","year":"2024","unstructured":"Kaya-Yasar, Y. et al. The contribution of the WNT pathway to the therapeutic effects of montelukast in experimental murine airway inflammation induced by ovalbumin and lipopolysaccharide. Drug Dev. Res. 85, e22178. https:\/\/doi.org\/10.1002\/ddr.22178 (2024).","journal-title":"Drug Dev. Res."},{"key":"46514_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa, H., Ohishi, N. & Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351\u2013358. https:\/\/doi.org\/10.1016\/0003-2697(79)90738-3 (1979).","journal-title":"Anal. Biochem."},{"key":"46514_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"MS Moron","year":"1979","unstructured":"Moron, M. S., Depierre, J. W. & Mannervik, B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim. Biophys. Acta 582, 67\u201378. https:\/\/doi.org\/10.1016\/0304-4165(79)90289-7 (1979).","journal-title":"Biochim. Biophys. Acta"},{"key":"46514_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","volume":"47","author":"S Marklund","year":"1974","unstructured":"Marklund, S. & Marklund, G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47, 469\u2013474. https:\/\/doi.org\/10.1111\/j.1432-1033.1974.tb03714.x (1974).","journal-title":"Eur. J. Biochem."},{"key":"46514_CR27","doi-asserted-by":"publisher","first-page":"403291","DOI":"10.1155\/2015\/403291","volume":"2015","author":"SL Badole","year":"2015","unstructured":"Badole, S. L., Chaudhari, S. M., Jangam, G. B., Kandhare, A. D. & Bodhankar, S. L. Cardioprotective activity of Pongamia pinnata in streptozotocin-nicotinamide induced diabetic rats. BioMed Res. Int. 2015, 403291. https:\/\/doi.org\/10.1155\/2015\/403291 (2015).","journal-title":"BioMed Res. Int."},{"key":"46514_CR28","doi-asserted-by":"publisher","first-page":"808731","DOI":"10.1155\/2013\/808731","volume":"2013","author":"A Er","year":"2013","unstructured":"Er, A., Dik, B., Corum, O. & Cetin, G. Cardiac safety of diclofenac at a single dose in ram. Sci. World J. 2013, 808731. https:\/\/doi.org\/10.1155\/2013\/808731 (2013).","journal-title":"Sci. World J."},{"key":"46514_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12012-017-9414-2","volume":"18","author":"SS Oda","year":"2018","unstructured":"Oda, S. S. & Derbalah, A. E. Impact of diclofenac sodium on tilmicosin-induced acute cardiotoxicity in rats (tilmicosin and diclofenac cardiotoxicity). Cardiovasc. Toxicol. 18, 63\u201375. https:\/\/doi.org\/10.1007\/s12012-017-9414-2 (2018).","journal-title":"Cardiovasc. Toxicol."},{"key":"46514_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/cdd.2017.186","volume":"25","author":"J Kale","year":"2018","unstructured":"Kale, J., Osterlund, E. J. & Andrews, D. W. BCL-2 family proteins: Changing partners in the dance towards death. Cell Death Differ. 25, 65\u201380. https:\/\/doi.org\/10.1038\/cdd.2017.186 (2018).","journal-title":"Cell Death Differ."},{"key":"46514_CR31","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1091\/mbc.11.10.3509","volume":"11","author":"K Kim","year":"2000","unstructured":"Kim, K., Pang, K. M., Evans, M. & Hay, E. D. Overexpression of \u03b2-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. Mol. Biol. Cell 11, 3509\u20133519. https:\/\/doi.org\/10.1091\/mbc.11.10.3509 (2000).","journal-title":"Mol. Biol. Cell"},{"key":"46514_CR32","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1091\/mbc.e03-01-0865","volume":"14","author":"D Olmeda","year":"2003","unstructured":"Olmeda, D., Castel, S., Vilar\u00f3, S. & Cano, A. \u03b2-catenin regulation during the cell cycle: Implications in G2\/M and apoptosis. Mol. Biol. Cell 14, 2844\u20132860. https:\/\/doi.org\/10.1091\/mbc.e03-01-0865 (2003).","journal-title":"Mol. Biol. Cell"},{"key":"46514_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13619-015-0017-8","volume":"4","author":"G Ozhan","year":"2015","unstructured":"Ozhan, G. & Weidinger, G. Wnt\/\u03b2-catenin signaling in heart regeneration. Cell Regen. 4, 3. https:\/\/doi.org\/10.1186\/s13619-015-0017-8 (2015).","journal-title":"Cell Regen."},{"key":"46514_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.14670\/hh-21.103","volume":"21","author":"F Li","year":"2006","unstructured":"Li, F., Chong, Z. Z. & Maiese, K. Winding through the WNT pathway during cellular development and demise. Histol. Histopathol. 21, 103\u2013124. https:\/\/doi.org\/10.14670\/hh-21.103 (2006).","journal-title":"Histol. Histopathol."},{"key":"46514_CR35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/hypertensionaha.109.141127","volume":"55","author":"P Malekar","year":"2010","unstructured":"Malekar, P. et al. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. Hypertension 55, 939\u2013945. https:\/\/doi.org\/10.1161\/hypertensionaha.109.141127 (2010).","journal-title":"Hypertension"},{"key":"46514_CR36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/cvr\/cvw214","volume":"112","author":"M Matteucci","year":"2016","unstructured":"Matteucci, M. et al. Magnetic resonance imaging of infarct-induced canonical wingless\/integrated (Wnt)\/\u03b2-catenin\/T-cell factor pathway activation, in vivo. Cardiovasc. Res. 112, 645\u2013655. https:\/\/doi.org\/10.1093\/cvr\/cvw214 (2016).","journal-title":"Cardiovasc. Res."},{"key":"46514_CR37","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1023\/a:1016056912698","volume":"13","author":"H Cheng","year":"1996","unstructured":"Cheng, H. et al. Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females. Pharm. Res. 13, 445\u2013448. https:\/\/doi.org\/10.1023\/a:1016056912698 (1996).","journal-title":"Pharm. Res."},{"key":"46514_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00021.2015","volume":"97","author":"V Regitz-Zagrosek","year":"2017","unstructured":"Regitz-Zagrosek, V. & Kararigas, G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol. Rev. 97, 1\u201337. https:\/\/doi.org\/10.1152\/physrev.00021.2015 (2017).","journal-title":"Physiol. Rev."},{"key":"46514_CR39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/509282a","volume":"509","author":"JA Clayton","year":"2014","unstructured":"Clayton, J. A. & Collins, F. S. Policy: NIH to balance sex in cell and animal studies. Nature 509, 282\u2013283. https:\/\/doi.org\/10.1038\/509282a (2014).","journal-title":"Nature"},{"key":"46514_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pharmthera.2012.03.007","volume":"135","author":"AA Knowlton","year":"2012","unstructured":"Knowlton, A. A. & Lee, A. R. Estrogen and the cardiovascular system. Pharmacol. Ther. 135, 54\u201370. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.03.007 (2012).","journal-title":"Pharmacol. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46514-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46514-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46514-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T23:13:21Z","timestamp":1775690001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46514-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46514"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46514-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11717"}}